+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Leprosy Drug"

Current Perspectives on Anti-Infective Agents - Product Thumbnail Image

Current Perspectives on Anti-Infective Agents

  • Book
  • November 2019
  • 278 Pages
From
  • 3 Results (Page 1 of 1)
Loading Indicator

Leprosy is a chronic infectious disease caused by the bacteria Mycobacterium leprae. It is primarily spread through contact with an infected person, and can cause severe disfigurement and disability if left untreated. Treatment of leprosy is typically done with a combination of antibiotics, including dapsone, rifampicin, and clofazimine. These drugs are used to reduce the bacterial load in the body, and to prevent the spread of the disease. The leprosy drug market is a subset of the larger infectious diseases drug market. It is composed of drugs used to treat leprosy, as well as other drugs used to treat related conditions, such as skin infections. The market is highly competitive, with a number of companies offering different formulations of the same drugs. Some of the companies in the leprosy drug market include Novartis, GlaxoSmithKline, Sanofi, Pfizer, and Merck. These companies offer a variety of formulations of the drugs used to treat leprosy, as well as other drugs used to treat related conditions. Show Less Read more